Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 02 04:00PM ET
3.96
Dollar change
-0.11
Percentage change
-2.70
%
Index- P/E- EPS (ttm)-0.52 Insider Own10.73% Shs Outstand71.42M Perf Week4.21%
Market Cap301.37M Forward P/E- EPS next Y-0.52 Insider Trans208.70% Shs Float63.76M Perf Month118.78%
Income-37.00M PEG- EPS next Q-0.25 Inst Own75.64% Short Float2.45% Perf Quarter244.35%
Sales27.08M P/S11.13 EPS this Y41.73% Inst Trans52.48% Short Ratio0.72 Perf Half Y280.77%
Book/sh1.82 P/B2.17 EPS next Y29.73% ROA-18.47% Short Interest1.56M Perf Year352.73%
Cash/sh1.68 P/C2.36 EPS next 5Y- ROE-25.83% 52W Range0.80 - 5.17 Perf YTD277.14%
Dividend Est.- P/FCF- EPS past 5Y20.67% ROI-27.95% 52W High-23.40% Beta0.46
Dividend TTM- Quick Ratio7.03 Sales past 5Y74.29% Gross Margin53.53% 52W Low395.00% ATR (14)0.45
Dividend Ex-Date- Current Ratio7.03 EPS Y/Y TTM68.83% Oper. Margin-208.45% RSI (14)63.70 Volatility10.36% 16.07%
Employees91 Debt/Eq0.02 Sales Y/Y TTM26.35% Profit Margin-136.65% Recom1.57 Target Price7.60
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q74.27% Payout- Rel Volume0.49 Prev Close4.07
Sales Surprise175.94% EPS Surprise-1829.82% Sales Q/Q-53.18% EarningsNov 06 BMO Avg Volume2.17M Price3.96
SMA2025.95% SMA5094.10% SMA200179.77% Trades Volume1,052,033 Change-2.70%
Date Action Analyst Rating Change Price Target Change
Nov-20-24Upgrade Cantor Fitzgerald Neutral → Overweight
Nov-19-24Upgrade Leerink Partners Market Perform → Outperform $2 → $7
Nov-19-24Upgrade Jefferies Hold → Buy $2 → $7
Nov-19-24Upgrade BTIG Research Neutral → Buy $8
Nov-18-24Upgrade Piper Sandler Neutral → Overweight $3 → $13
Jan-22-24Downgrade H.C. Wainwright Buy → Neutral
Nov-13-23Downgrade William Blair Outperform → Mkt Perform
Oct-03-23Initiated Evercore ISI Outperform $22
Dec-14-22Initiated Stifel Buy $29
Dec-01-22Initiated Goldman Buy $25
Nov-26-24 04:30PM
Nov-20-24 05:11AM
Nov-19-24 09:30PM
03:27PM
11:00AM
08:50AM Loading…
Nov-18-24 08:50AM
08:10AM
08:10AM
Nov-06-24 08:05AM
07:07AM
07:00AM
Oct-09-24 07:02PM
Sep-18-24 06:52AM
Sep-17-24 07:00AM
Sep-10-24 07:00AM
08:15AM Loading…
Aug-07-24 08:15AM
07:20AM
07:00AM
Jul-25-24 09:40AM
Jul-16-24 04:01PM
Jul-02-24 01:27PM
Jun-06-24 07:00AM
May-08-24 12:06PM
07:43AM
04:06AM
May-07-24 10:56PM
05:15PM
04:11PM
04:01PM
Apr-30-24 07:00AM
08:00AM Loading…
Apr-23-24 08:00AM
Apr-05-24 09:40AM
Mar-20-24 09:40AM
Mar-14-24 08:45AM
Mar-04-24 12:00PM
09:40AM
Feb-27-24 09:35AM
08:38AM
07:00AM
Feb-15-24 10:00AM
Feb-13-24 09:40AM
Jan-17-24 11:14AM
Jan-16-24 07:00AM
Jan-10-24 07:00AM
Jan-04-24 09:40AM
Dec-19-23 04:01PM
Dec-05-23 04:01PM
Dec-04-23 09:35AM
Nov-16-23 09:35AM
Nov-14-23 10:57AM
Nov-13-23 07:17AM
07:06AM
07:00AM
Nov-06-23 08:03AM
07:06AM
07:00AM
Oct-03-23 07:00AM
Sep-20-23 07:00AM
Sep-18-23 07:00AM
Sep-14-23 07:03PM
Sep-08-23 05:06PM
Aug-10-23 06:07AM
Aug-08-23 08:40AM
Aug-07-23 08:15AM
07:10AM
07:00AM
Aug-01-23 07:53AM
Jul-06-23 08:19AM
Jun-26-23 10:15AM
Jun-13-23 06:30PM
07:01AM
Jun-02-23 07:00AM
May-18-23 01:50PM
May-10-23 06:04AM
May-08-23 11:55PM
08:15AM
07:08AM
07:00AM
May-05-23 06:49AM
May-02-23 07:01AM
Apr-27-23 04:35AM
Apr-24-23 02:37PM
Apr-04-23 07:40AM
Mar-27-23 07:00AM
Mar-10-23 11:34AM
Mar-06-23 03:59PM
02:32PM
01:03PM
11:50AM
07:00AM
Feb-23-23 08:35AM
07:00AM
Feb-22-23 06:01AM
Feb-09-23 04:01PM
Jan-06-23 07:01AM
Nov-29-22 07:00AM
Nov-26-22 01:39PM
Nov-22-22 04:01PM
Nov-16-22 12:10PM
Nov-10-22 04:01PM
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mehra AnandDirectorNov 19 '24Buy2.25666,6661,499,998710,030Nov 20 04:20 PM
Walker NealINTERIM PRESIDENT AND CEOAug 09 '24Option Exercise0.7243,54831,3551,356,153Aug 13 04:15 PM
Leonard Braden Michael10% OwnerAug 05 '24Buy1.24206,025256,35714,250,000Aug 05 03:57 PM
Leonard Braden Michael10% OwnerAug 02 '24Buy1.29167,544216,40014,043,975Aug 05 03:57 PM
Leonard Braden Michael10% OwnerJul 30 '24Buy1.30173,730226,37013,776,421Jul 31 04:10 PM
Leonard Braden Michael10% OwnerJul 31 '24Buy1.33100,000132,64013,876,421Jul 31 04:10 PM
Leonard Braden Michael10% OwnerJul 18 '24Buy1.30130,317169,55513,578,286Jul 22 04:03 PM
Leonard Braden Michael10% OwnerJul 22 '24Buy1.3317,71623,55713,602,691Jul 22 04:03 PM
Leonard Braden Michael10% OwnerJul 19 '24Buy1.306,6898,69613,584,975Jul 22 04:03 PM
Leonard Braden Michael10% OwnerJul 03 '24Buy1.16143,288166,07113,324,952Jul 05 02:46 PM
Leonard Braden Michael10% OwnerJul 05 '24Buy1.15123,017141,33413,447,969Jul 05 02:46 PM
Leonard Braden Michael10% OwnerJul 02 '24Buy1.1486,09298,48913,181,664Jul 05 02:46 PM
Leonard Braden Michael10% OwnerJun 28 '24Buy1.121,201,0001,348,55912,988,134Jul 01 01:39 PM
Leonard Braden Michael10% OwnerJun 27 '24Buy1.15235,000271,33111,787,134Jul 01 01:39 PM
Leonard Braden Michael10% OwnerJul 01 '24Buy1.14107,434122,18513,095,572Jul 01 01:39 PM
Leonard Braden Michael10% OwnerJun 14 '24Buy1.17345,000402,20111,352,134Jun 18 04:04 PM
Leonard Braden Michael10% OwnerJun 17 '24Buy1.13150,000169,50011,502,134Jun 18 04:04 PM
Leonard Braden Michael10% OwnerJun 18 '24Buy1.1350,00056,50511,552,134Jun 18 04:04 PM
Leonard Braden Michael10% OwnerJun 11 '24Buy1.081,000,0001,080,00010,395,934Jun 13 06:04 PM
Leonard Braden Michael10% OwnerJun 13 '24Buy1.15528,621607,75711,007,134Jun 13 06:04 PM
Leonard Braden Michael10% OwnerJun 12 '24Buy1.1482,57994,14010,478,513Jun 13 06:04 PM
Powell Andrew Kenneth WilliamDirectorMar 01 '24Buy1.238,50010,45522,863Mar 05 04:58 PM
Powell Andrew Kenneth WilliamDirectorMar 04 '24Buy1.256,0007,50028,863Mar 05 04:58 PM